摘要
AIM： To evaluate the effect of three interventional treatments involving transvenous obliteration for the treatment of gastric varices, and to compare the efficacy and adverse effects of these methods, METHODS： From 1995 to 2004, 93 patients with gastric fundal varices underwent interventional radiologic embolotherapy at our hospital. Of the 93 patients, 75 were treated with the balloon-occluded retrograde transvenous obliteration （BRTO） procedure; 8 were with the percutaneous transhepatic obliteration （PTO） procedure; and 10 were with the combined BRTO and PTO therapy. A follow-up evaluation examined the rates of survival, recurrence and rebleeding of the gastric varices, worsening of esophageal varices and complications in each group. RESULTS： The BRTO, PTO, and combined therapy were technically successful in 81% （75/93）, 44% （8/18）, and 100% （10/10） patients, respectively. Recurrence of gastric varices was found in 3 patients in the BRTO group and in 3 patients in the PTO group. Rebleeding was observed in 1 patient in the BRTO group and in 1 patient in the PTO group. The 1- and 3-year survival rates were 98% and 87% in the patients without hepatocellular carcinoma （HCC） in the BRTO group, 100% and 100% in the PTO group, and 90% and 75% in the combined therapy group, respectively. CONCLUSION： Combined BRTO and PTO therapy may rescue cases with uncontrollable gastric fundal varices that remained even after treatment with BRTO and/or PTO, though there were limitations of our study, including retrospective nature and discrepancy in sample size between the BRTO, PTO and combined therapy groups.
瞄准：评估为胃的静脉曲张的处理包含 transvenous 涂去的三个 interventional 处理的效果，并且比较功效和这些方法的不利效果。方法：从 1995 ～ 2004，有胃的底的静脉曲张的 93 个病人经历了 interventional 在我们的医院的放射线学的 embolotherapy。93 个病人， 75 被对待与堵塞汽球后退 transvenous 涂去(BRTO ) 过程；8 与经皮的 transhepatic 涂去(PTO ) 是过程；并且 10 与联合 BRTO 和 PTO 治疗。后续评估检验了幸存的率，复发并且胃的静脉曲张重新流血，在每个组食道的静脉曲张和复杂并发症变得更坏。结果：BRTO， PTO，和联合治疗在 81% 是技术上成功的(75/93 ) ， 44%(8/18 ) ，并且 100%(10/10 ) 病人分别地。胃的静脉曲张的复发在 PTO 组在 BRTO 组并且在 3 个病人在 3 个病人被发现。重新流血在 PTO 组在 BRTO 组并且在 1 个病人在 1 个病人被观察。没有肝细胞癌(HCC ) ， 1 年、 3 年的幸存率在在 PTO 组的 BRTO 组， 100% 和 100% 在病人是 98% 和 87% ，并且 90% 和 75% 分别地在联合治疗组织。结论：尽管有我们的学习的限制，联合 BRTO 和 PTO 治疗可以与与 BRTO 或 PTO 仍然是甚至术后疗法的控制不了的胃的底的静脉曲张救盒子，包括在在 BRTO， PTO 和联合治疗组之间的样品尺寸的回顾的自然和差异。
